Pharmaceuticals
Developers of branded and generic drugs. Value creation rests on R&D pipelines, patent lifecycles, regulatory approvals and pricing power versus payers.
| Unternehmen | Letzter Kurs | Kursänderung | Marktkapitalisierung | ||
|---|---|---|---|---|---|
|
|
|
Eli Lilly and Co
LLY
|
$1.347,11 |
-0,3%
|
$1,27 Bio. |
|
|
|
Johnson & Johnson
JNJ
|
$270,47 |
+1,2%
|
$651,11 Mrd. |
|
|
|
Merck & Co Inc
MRK
|
$133,72 |
+0,7%
|
$329,91 Mrd. |
|
|
|
Novartis AG
NOVN
|
CHf127,76 |
+0,4%
|
$289,22 Mrd. |
|
|
|
AstraZeneca PLC
AZN
|
13.412 |
+0,8%
|
$272,10 Mrd. |
|
|
|
Novo Nordisk A/S
NOVO B
|
kr264,5 |
-0,2%
|
$171,25 Mrd. |
|
|
|
Pfizer Inc
PFE
|
$27,4 |
-0,5%
|
$156,16 Mrd. |
|
|
|
Bristol-Myers Squibb Co
BMY
|
$58,8 |
+0,8%
|
$120,19 Mrd. |
|
|
|
Sanofi SA
SAN
|
€84,92 |
+1,3%
|
$112,56 Mrd. |